Swiss Investment Fund
for Emerging Markets

Abacus Parenteral Drugs Ltd

2011 | 
Santé | 
Ouganda
Retour
Un investissement du fonds https://sifem.ch/investment/africinvest-fund-ii/
axé sur le secteur Santé
en Ouganda

Abacus Parenteral Drugs Ltd

2011
 | Santé
 | Ouganda
Un investissement du fonds https://sifem.ch/investment/africinvest-fund-ii/
axé sur le secteur Santé
en Ouganda

Abacus Parenteral Drugs Limited (APDL) is one of the largest sterile injectables pharmaceutical companies in East Africa, with its state-of-the-art manufacturing facility located in Uganda. It produces a range of lifesaving intravenous infusion products as well as eye, ear and nose drops mainly catering to government and private hospitals, aid agencies, and nursing homes. SIFEM invested into APDL via AfricInvest II in 2011.

Liens

A propos du fonds: 
https://sifem.ch/investment/africinvest-fund-ii/
A propos de l'entreprise: 

Télécharger l'étude de cas

Télécharger l'étude de cas​

Dernières nouvelles

« Real people doing real things »: SIFEM’s chairs in conversation at the EDFI Meeting in Lugano

As Jörg Frieden steps down after eight years as Chair of SIFEM’s Board of Directors, and Mirjam Staub-Bisang takes up the role, the outgoing and incoming chairs sit down together to reflect on impact, conviction, and the business of putting capital to good use.

Dernières nouvelles

« Real people doing real things »: SIFEM’s chairs in conversation at the EDFI Meeting in Lugano

As Jörg Frieden steps down after eight years as Chair of SIFEM’s Board of Directors, and Mirjam Staub-Bisang takes up the role, the outgoing and incoming chairs sit down together to reflect on impact, conviction, and the business of putting capital to good use.